Xcel Energy Could Year-End Rally as UBS Sees Value
UBS boosts its price target on Xcel Energy to $89 while maintaining a Buy rating, saying the stock could year-end hig...
We compare index funds and target date funds for retirement to help you decide based on time horizon, risk tolerance, costs, and tax considerations.
26,044 articlesUBS boosts its price target on Xcel Energy to $89 while maintaining a Buy rating, saying the stock could year-end hig...
When a tech icon hints at a trillion-dollar future, investors listen. This article breaks down the math, the bets, an...
UBS raises AMD’s target to $670, a sharp upgrade that highlights strong AI-driven data center demand. Traders watch f...
Analysts boosted targets on UNFI and MTDR after solid quarterly results, signaling renewed investor optimism as pipel...
UBS cuts Mosaic’s price target to $27, citing squeezed phosphate margins from higher sulfur and input costs, as Wall ...
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
A major biotech takeover bid sets the tone for today’s market. AbbVie’s cash offer for Apogee Therapeutics sent share...
Analysts convene Thursday to highlight key stock moves ahead of a holiday weekend, with fresh targets and cautions ac...
Wednesday brought a wave of fresh analyst calls spanning tech, industrials, and defense as traders weigh earnings and...
Kinross Gold posted a solid Q4 print after the bell, beating expectations with $0.67 in adjusted EPS and outlining 20...
One prominent chartist argues XRP could surge to $42 by 2026, but rivals say the move would require unprecedented ins...
Citi lifts Celanese's price target to 81 amid rising Iran risk and potential Strait of Hormuz disruption, pointing to...